Tracker › Companies › Sionna Therapeutics, Inc.
3 No sign of it. We found no public evidence tying Sionna Therapeutics, Inc.'s cuts to AI.
Every tracked 2026 layoff at Sionna Therapeutics, Inc., newest first. Scores are 0–100: how strongly the public evidence ties the cuts to AI. Sources are linked on each one.
AI score 3/100 (Minimal) · 80% interval 2–3 · evidence grade D · US · Pharma / Chemicals
Stated reason: On September 9, 2026, the Board of Directors (the “Board”) of Sionna Therapeutics, Inc. (the “Company”) approved a restructuring plan (the “Restructuring”) intended to focus its resources on advancing the Company’s SION-451 and SION-2222 dual combination program and extend the Company’s cash runway. The Restructuring includes a reduction of the Company’s workforce by approximately 46%, retaining core clinical, regula…
Why 3: Plant, store or site closure · Drivers: contrary evidence −0.7, industry AI exposure +0.5
Evidence: SEC filing. Signals: attribution 0.0, primary source 0.0, exec statement 0.0, role exposure 0.608, industry exposure 0.712, AI investment 0.0, contrary evidence 0.4 · named roles: Computer and Information Systems Managers, General and Operations Managers, Nursing Assistants, Registered Nurses
Headcount basis: not disclosed
Scores are evidence-based estimates from a published model, not findings that AI caused any layoff. Spot something wrong or missing? Tell us.
Other Health Care & Pharma layoffs we track.
Health Care & Pharma · 3,800 workers
Health Care & Pharma · 648 workers
Health Care & Pharma · 419 workers
Health Care & Pharma · 365 workers
Health Care & Pharma · 300 workers
Health Care & Pharma · 120 workers
